01.06.12
Fertility Nutraceuticals, LLC, New York, NY, has launched Fertinatal micronized dehydroepiandrosterone (DHEA) supplement, which is designed to augment female fertility. Physicians at New York’s Center for Human Reproduction (CHR), a leading fertility and research center, initiated research on the relationship between DHEA supplementation and enhanced female fertility. Although research on the effects of DHEA is still limited, the published results of CHR’s studies are encouraging, according to the company. Fertinatal features the highest quality control standards, including a triple-step testing process with batch-testing by independent laboratories. Furthermore, Fertinatal is micronized to the same particle sizes as used in clinical studies.